Skip to main content
Clinical Trials/NCT00512330
NCT00512330UnknownNot Applicable

Evaluation of Urine Lipoarabinomannan ELISA In Diagnostics of Childhood Tuberculosis

University Hospital, Bonn1 site in 1 country250 target enrollmentStarted: August 2007Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
250
Locations
1

Study Overview

Brief Summary

In children, it remains quite difficult even in developed countries, to prove a diagnosis of Tuberculosis (TB). New means for diagnosis of this disease are currently being researched. One candidate test is Lipoarabinomannan ELISA from Urine, which has shown good sensitivity of up to 80% in adults.

Our study aims to evaluate this test in the diagnosis of children with TB.

Detailed Description

Among candidate new diagnostics for TB, a test for mycobacterial Lipoarabinomannan (LAM) excretion in urine has shown promising results in one Tanzanian study: The sensitivity for detecting TB culture-positive patients was 80.3%. Of 103 healthy volunteers, only one gave a false positive result (Boehme, 2005).

Until now, there are only data concerning this test for diagnosis of adult disease. For evaluation of routine use in children in countries like Malawi, we are starting a prospective study. Children 0-14 years of age with suspected TB will be investigated using TB culture as the gold standard. In sputum samples, microscopy will be done. Simultaneously, LAM Elisa from the patient´s urine will be done.

Study Design

Study Type
Observational
Time Perspective
Prospective

Eligibility Criteria

Ages
— to 14 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • age 0-14 years
  • suspicion of active TB or TB contact

Exclusion Criteria

  • no informed consent

Investigators

Sponsor
University Hospital, Bonn
Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials